In a double-blind, placebo-controlled pilot study, the levels of alanine aminotransferase and liver ultrasound brightness were improved after short-term probiotic Lactobacillus rhamnosus strain GG administration in patients with NAFLD (Vajro et al., 2011). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.